Long-term prognostic significance of complex ventricular arrhythmias induced during Dobutamine stress echocardiography

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 242-244

  De Sutter, Johan ^a,b   Poldermans, Don ^a,b   Vourvouri, Eleni ^a,b   Van Donburg, Ron ^a,b   Elhendy, Abdou ^a,b   Bax, Jeroen ^a,b   Sozzi, Fabiola ^a,b   Jordaens, Luc ^a,b   De Buyzere, Marc ^a,b   Roelandt, Jos ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; STRESS; STRESS ECHOCARDIOGRAPHY;

ARRHYTHMIA; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037299764     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03118-1     Document Type: Article

References (18)

1. Geleijnse M.L., Fioretti P.M., Roelandt J.R.T.C. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 30:1997;595-606.
2. Marwick T.H., Case C., Sawada S., Rimmerman C., Brenneman P., Kovacs R., Short L., Lauer M. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 37:2001;754-760.
3. Poldermans D., Arnese M., Fioretti P.M., Salustri A., Boersma E., Thomson I.R., Roelandt J.R.T.C. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiogaphy. J Am Coll Cardiol. 26:1995;648-653.
4. Sciari R., Picano E., Landi P., Pingitori A., Bigi R., Coletta C., Meyman J., Casazza F., Previtali M., Mathas W., et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol. 29:1997;254-260.
5. Carlos M.E., Smart S.C., Wynsen J.C., Sagar K.B. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation. 95:1997;1402-1410.
6. Williams M.J., Odabashian J., Lauer M.S., Thomas J.D., Marwick T.H. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
7. Poldermans D., Fioretti P.M., Boersma E., Bax J.J., Thomson I.R., Roelandt J.R.T.C., Simoons M.L. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease. A single-center experience. Circulation. 99:1999;757-762.
8. Mertes H., Sawasa S.G., Ryan D.C., Kovacs R., Foltz J., Feigenbaum H. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography, experience in 1118 patients. Circulation. 88:1993;15-19.
9. Poldermans D., Fioretti P.M., Boersma E., Forster T., Van Urk M., Cornel J.M., Arnese M., Roelandt J.R.T.C. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol. 73:1994;456-459.
10. Poldermans D., Rambaldi R., Bax J.J., Cornel J.M., Thomson I.R., Valkema R., Boersma E., Fioretti P.M., Breburda M., Roelandt J.R.T.C. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J. 19:1998;1712-1718.
11. Picano E., Mathias W., Pingitore A., Bigi R., Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography a prospective, multicentre study. Lancet. 344:1994;1190-1192.
12. Mathias W., Arruda A., Santos F.C., Arruda A.L., Mattos E., Osorio A., Campos O., Gil M., Andrade J.L., Carvalho A.C. Safety of dobutamine-atropine stress echocardiography a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr. 12:1999;785-791.
13. Secknus M.A., Marwick T.H. Evolution of dobutamine echocardiography protocols and indications safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol. 29:1997;1234-1240.
14. Edwards W.D., Tajik A.J., Seward J.B. Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. Mayo Clin Proc. 56:1981;479-497.
15. Bourdillon P.D.V., Broderick T.M., Sawada S.G., Armstrong W.F., Ryan T., Dillon J.C., Feinberg N.S., Feigenbaum H. Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction comparison with global wall motion index. J Am Soc Echocardiogr. 2:1989;398-407.
16. Bigi R., Partesana N., Verzoni A., Bandini P., Maffi M., Longoni A., Occhi G., Fiorentini C. Incidence and correlates of complex ventricular arrhythmias during dobutamine stress echocardiography after acute myocardial infarction. Eur Heart J. 16:1995;1819-1824.
17. Elhendy A., van Domburg R.T., Bax J.J., Roelandt J.R.T.C. Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography. Am J Cardiol. 83:1999;832-835.
18. Chauvel C, Cohen A, Khireddine M. Safety of dobutamine stress echocardiography. Eur Heart J 1996;17:1898-1901.